M 40401
Alternative Names: M40401Latest Information Update: 27 May 2008
Price :
$50 *
At a glance
- Originator MetaPhore Pharmaceuticals
- Class Anti-inflammatories; Anti-ischaemics; Small molecules
- Mechanism of Action Oxygen radical scavengers; Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections; Neurological disorders; Reperfusion injury
Most Recent Events
- 02 Apr 2008 ActivBiotics sells its intellectual property assets including drug product candidates
- 18 Dec 2007 Suspended - Preclinical for HIV infections treatment in USA (unspecified route)
- 18 Dec 2007 Suspended - Preclinical for Neurological disorders in Japan (unspecified route)